AGN

Pharma

Botox maker Allergan expands R&D in U.S., defies outsourcing trend (and wrinkles)

The trend of outsourcing research and development work that spurred massive layoffs by pharmaceutical companies and the growth of the contract research organization industry doesn’t seem to be in Allergan’s (NYSE:AGN) playbook. The drug and device maker famous for its anti-wrinkle treatment Botox has opened a 93,000-square-foot R&D facility in New Jersey that is expected […]

By Stephanie Baum

Devices & Diagnostics

FDA approves Allergan weight-loss Lap-Band for more patients

Allergan's Lap-Band will now be available for a new group of obese patients. It used to be available only to people with a body mass index of 40 or at least 100 pounds over their ideal weight. Now, patients with a body mass index as low as 30 may be eligible to use the innovative medical device for weight loss. The announcement could increase sales by 51 percent to at least $390 million by 2016.

By MassDevice Staff

Health IT

Reducing Clinical and Staff Burnout with AI Automation

As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.

By Dr. Michael Blackman, Chief Medical Officer at Greenway Health

The Funding Model for Cancer Innovation is Broken — We Can Fix It

Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.

By Eve McDavid - CEO of Mission-Driven Tech

Health IT

Transforming Patient Care: The Role of AI-Powered Assistants

The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.

By IT Medical

Health IT

Transforming Patient Care: The Role of AI-Powered Assistants

The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.

By IT Medical